Facebook Twitter LinkedIn Email

Therapeutics Under Early Investigation

Last updated: September 3, 2020

The following is a curated review of key information and literature about this topic. It is not comprehensive of all data related to this subject.

Overview

There are many therapeutics under early investigation for treatment of COVID-19 for which there is currently insufficient clinical data to recommend either for or against. This overview is not a comprehensive summary, but a list of therapeutics with strong biological plausibility that are available in the United States and are or will be studied by clinical trial.

Theraputics Under Investigation pic.png

*Published clinical studies (including preprints). Excludes case reports and case series.

Sign up for IDSA's Newsletter
Stay informed with daily resources, media and news.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.